Clinical Ink partnered with Integron to leverage their experience managing devices and data throughout the world to ensure we can meet our customers’ IoT provisioning demands for clinical trials, globally.

Rochester, NY (PRWEB)June 19, 2017

Clinical Ink, the pioneering provider of eSource and patient engagement technologies, and Integron, a leading provider of managed services for the connected health and Internet of Things (IoT) industry, have partnered to extend Clinical Ink’s mobile device and sensor deployment capabilities to engage and collect data from patients in clinical trials.

“More and more clinical trial sponsors want to leverage mobile devices to engage patients and capture study data anytime and anywhere,” said Jonathan Andrus, chief operating officer, Clinical Ink. “SureSource Engage gives sponsors the option to deploy an integrated ePRO, patient engagement and IoT platform that integrates with multiple sensors in either a provisioned or a Bring-Your-Own-Device (BYOD) model. We partnered with Integron to leverage their experience managing devices and data throughout the world to ensure we can meet our customers’ IoT provisioning demands for clinical trials, globally.”